Literature DB >> 9805184

Beneficial effect of phlebotomy on hepatitis C virus-associated musculoskeletal manifestations.

N Hilzenrat1, D Buskila, D Zilberman, E Sikuler.   

Abstract

Chronic hepatitis C virus (HCV) infection may lead to many extrahepatic manifestations which pose a serious therapeutic challenge. Recently, increasing evidence suggesting an association between iron overload and chronic HCV infection has emerged. However, the effect of iron reduction therapy on extrahepatic manifestations of HCV infection is unknown. We describe two patients with chronic HCV infection and severe rheumatic manifestations, namely: myalgia and seronegative nonerosive symmetrical polyarthritis. Interestingly, the response to anti-inflammatory and second line drugs was poor but unexpectedly recurrent phlebotomies was followed by marked improvement of the symptoms. This observation suggests that iron overload may have some role in the pathophysiology of HCV associated rheumatic complications. Further studies are needed to confirm our observation and to clarify the underlying mechanism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9805184     DOI: 10.1007/bf01450898

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  10 in total

1.  Deferoxamine induced decreases of lipid peroxides in rheumatoid arthritis.

Authors:  E J Fudman; G O Till; I H Fox
Journal:  J Rheumatol       Date:  1987-08       Impact factor: 4.666

2.  Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C.

Authors:  N K Beinker; M D Voigt; M Arendse; J Smit; I A Stander; R E Kirsch
Journal:  J Hepatol       Date:  1996-11       Impact factor: 25.083

Review 3.  The spectrum of extrahepatic manifestations in hepatitis C virus infection.

Authors:  S J Hadziyannis
Journal:  J Viral Hepat       Date:  1997-01       Impact factor: 3.728

Review 4.  Hepatitis C virus and rheumatic disease.

Authors:  M H Wener; R J Johnson; E H Sasso; D R Gretch
Journal:  J Rheumatol       Date:  1996-06       Impact factor: 4.666

Review 5.  Iron and chronic viral hepatitis.

Authors:  H L Bonkovsky; B F Banner; A L Rothman
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

Review 6.  Metal-induced hepatotoxicity.

Authors:  R S Britton
Journal:  Semin Liver Dis       Date:  1996-02       Impact factor: 6.115

Review 7.  Side effects of alpha interferon.

Authors:  P F Renault; J H Hoofnagle
Journal:  Semin Liver Dis       Date:  1989-11       Impact factor: 6.115

8.  A pilot study of corticosteroid priming for lymphoblastoid interferon alfa in patients with chronic hepatitis C.

Authors:  K Chayama; A Tsubota; M Kobayashi; M Hashimoto; Y Miyano; H Koike; M Kobayashi; I Koida; Y Arase; S Saitoh; N Murashima; K Ikeda; H Kumada
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

9.  Treatment of rheumatoid arthritis with desferrioxamine.

Authors:  R J Polson; A S Jawad; A Bomford; H Berry; R Williams
Journal:  Q J Med       Date:  1986-12

10.  Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron.

Authors:  H Hayashi; T Takikawa; N Nishimura; M Yano; T Isomura; N Sakamoto
Journal:  Am J Gastroenterol       Date:  1994-07       Impact factor: 10.864

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.